Core Laboratories Q4 Earnings Beat Estimates, Expenses Increase Y/Y
CLB expects revenues to range from $124 million to $130 million and earnings per share to be between 11 cents and 15 cents for the first quarter of 2026.
Core Laboratories Inc. (CLB) Q4 2025 Earnings Call Transcript
Core Laboratories Inc. (CLB) Q4 2025 Earnings Call Transcript
Core Laboratories (CLB) Beats Q4 Earnings and Revenue Estimates
Core Laboratories (CLB) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.22 per share a year ago.
What's in Store for Core Laboratories Stock in Q4 Earnings?
CLB is expected to report higher revenues than the year-ago period's level. However, it is expected to have faced increased costs and expenses.
Here's Why Hold Strategy Is Apt for Core Laboratories Stock for Now
CLB benefits from long-term industry investments and strong acquisitions, though its growth is modest and vulnerable to macroeconomic and geopolitical uncertainties.
Core Laboratories Inc. (CLB) Q3 2025 Earnings Call Transcript
Core Laboratories Inc. (NYSE:CLB ) Q3 2025 Earnings Call October 23, 2025 8:30 AM EDT Company Participants Lawrence Bruno - Chairman of the Board, CEO, President & COO Gwendolyn Schreffler - Senior Vice President of Corporate Development & Investor Relations Chris Hill - Senior VP & CFO Conference Call Participants John Daniel - Daniel Energy Partners, LLC Presentation Operator Good day, and welcome to the Core Laboratories Q3 2025 Earnings Call. [Operator Instructions] Please note, this event is being recorded.
Strength Seen in Core Laboratories (CLB): Can Its 6.0% Jump Turn into More Strength?
Core Laboratories (CLB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Core Laboratories Stock Rebounds in a Month: Is it Time to Buy?
CLB stock rebounds with 13% gains in a month, outpacing peers and the energy sector as revenues, margins and cash flow strengthen.
Core Laboratories: Not a Buy Yet, But Still Worth Holding On
CLB expands globally with new tech labs and energy transition projects while reducing debt but faces tariff pressures, U.S. market softness and demand volatility risks.
Core Laboratories Q2 Earnings Beat Estimates, Expenses Increase Y/Y
CLB's second-quarter earnings beat estimates. However, it declined year over year due to the underperformance of the Reservoir Description segment.
Core Laboratories Inc. (CLB) Q2 2025 Earnings Call Transcript
Core Laboratories Inc. (NYSE:CLB ) Q2 2025 Earnings Conference Call July 24, 2025 8:30 AM ET Company Participants Christopher Scott Hill - Senior VP & CFO Gwendolyn Y. Gresham - Senior Vice President of Corporate Development & Investor Relations Lawrence V.
Core Laboratories (CLB) Beats Q2 Earnings and Revenue Estimates
Core Laboratories (CLB) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.22 per share a year ago.
